Product Information
ERYTHROMYCIN 400 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.7573 per ML under NDC 60219150402. Its NADAC has been published 108 times since Jun 5, 2024.
Strength
400 mg/5mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219150402
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA211204On Market Since
12/2/2023
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has been published 108 times since Jun 5, 2024, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7573 per ML |
|---|---|
| All-time high | $2.2830 (Oct 15, 2025) |
| All-time low | $1.7573 (Jun 17, 2026) |
| 52-week high | $2.2830 |
| 52-week low | $1.7573 |
| Median price | $1.9394 |
| Average price | $1.9665 |
| Largest weekly change | -15.4% (Jul 17, 2024) |
| Weeks tracked | 108 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 400 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 400 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $1.7573 per ML (NDC 60219150402), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 400 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has declined 18.5%. It has been tracked across 108 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 400 MG/5 ML SUSP?
Since Jun 5, 2024, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has ranged from a low of $1.7573 (Jun 17, 2026) to a high of $2.2830 (Oct 15, 2025), with a median of $1.9394 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 400 MG/5 ML SUSP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ERYTHROMYCIN 400 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 400 MG/5 ML SUSP?
ERYTHROMYCIN 400 MG/5 ML SUSP (NDC 60219150402) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification